ArticleClinical and experimental medicine2019

PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors.

Yemarshet K Gebreyohannes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.